| Website | mitralign.com |
| Category | Consumer Electronics/Devices |
| Phone | 978.863.2400 |
| info@mitralign.com | |
| Employees |
| TOTAL | $35M |
| FUNDING TOTAL | $35M |
| Series D, 5/12 Forbion Capital Partners Saints Capital Oxford Bioscience Partners Triathlon Medical Venture Partners Medtronic Johnson & Johnson Development Corporation | $35M |
| DEBT TOTAL | $7M |
| Debt, 9/12 Horizon Technology Finance Management LLC | $7M |
Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening.
Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.
